We studied phosphorylation of Smad2 after treatment with TGF-β of UCMD and control cells and although we detected phosphorylation of Smad2 we did not find significant differences between patients and control cells (data not shown). The gene discussed is SMAD2; the disease is Congenital muscular dystrophy, Ullrich type.